State, local & non-profit
Elsevier offers researchers, managers, planners, policy makers and librarians who work at state, local or non-profit institutes:
• Specialized business models
• A variety of integrated tools, data, technology and authoritative information that suit each agency’s size and focus
The following online solutions for state, local & non-profit institutes are available:
Get the most from Elsevier's content by accessing Elsevier’s leading full-text scientific journal content online with ScienceDirect. ScienceDirect's extensive, easy-to-use and unique full-text database covers authoritative titles from the core scientific literature, including high-impact factor titles such as The Lancet, Cell and Tetrahedron. More than 2,500 journals, 11,000 books and more than ten million full-text articles are available in ScienceDirect.
- ScienceDirect article choice (one-off purchasing model)
Tap into ScienceDirect's vast repository of knowledge on an as-needed basis. ScienceDirect ArticleChoice provides a flexible way to access the content from the ScienceDirect platform. A logical and competitively priced alternative to document delivery services (ILL), you only pay for the information you need.
- ScienceDirect government edition
Currently government organizations in Europe, Asia Pacific Region, South Africa and Israel with limited print subscriptions qualify for ScienceDirect Government Edition.
When you're tackling complicated issues you need access to current, comprehensive information. ScienceDirect Government Edition - an access-based license option, especially developed for government organizations with up to 100 users - gives you affordable, online access to more than a quarter of the world's scientific, technical, economic and medical literature. ScienceDirect Government Edition info page.
- ScienceDirect backfiles
ScienceDirect Backfiles is a historical archive of journals from 1994 and older, many going back to Volume1, Issue 1. Together with more recent Backfiles, there are more than nine million articles in the portfolio. Backfiles allow you to retrieve scientific information that was not previously accessible electronically and is difficult or even impossible to locate in print. Backfiles help ensure that your collection is truly complete.
- Online books on ScienceDirect
The world's most authoritative online books and journals merge on ScienceDirect to provide the comprehensive and reliable content that researchers need—as well as the accessibility and searchability that researchers want—but cannot get from using printed works alone. There are many purchase options available for the Online Books on ScienceDirect collection, which includes eBooks, Book Series, Handbooks and Major Reference Works.
Scopus is the world’s largest abstract and citation database of peer-reviewed literature with smart tools that track, analyze and visualize research. Scopus covers more than 20,500 titles from 5,000 publishers. Easy to use and comprehensive, researchers can spend less time mastering databases and more time on research.
- SciVal Spotlight
Get an insightful multi-disciplinary perspective on your institution’s research performance. Using co-citation analysis of peer-reviewed journals, this new tool provides a precise ‘map’ of a country’s or an institution’s research strengths and distinctive competencies.
- Engineering Information
Engineering Village is the leader in providing online information, knowledge, and support of the highest professional relevance for research and industrial practitioners in the applied physical sciences and engineering. Engineering offers an array of products and services for universities including: Compendex®, EnCompass™, The Engineering Index®, Chemical Business NewsBase®, Chimica™ and PaperChem™.
The most comprehensive online source of biomedical answers for researchers working in the biomedical, clinical or regulatory fields. Embase is a comprehensive database, which holds over 20 million indexed records from more than 7,000 active, peer-reviewed journals. Helps you in tracking drug adverse events, comparing drug therapies for disease and in evidence-based medical research.